The network of psychological variables in patients with diabetes and their importance for quality of life and metabolic control
M Rose, H Fliege, M Hildebrandt, T Schirop… - Diabetes …, 2002 - Am Diabetes Assoc
OBJECTIVE—The primary goals in treating patients with diabetes are maintaining blood
glucose levels as close to normal as possible and making a relatively normal quality of life …
glucose levels as close to normal as possible and making a relatively normal quality of life …
[PDF][PDF] Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma
…, G Glatting, M Port, M Hildebrandt… - Journal of Nuclear …, 1997 - Soc Nuclear Med
Increased glycolysis is a characteristic metabolic feature of a malig nant transformed phenotype.
In cultured cells transformed by vi ruses or activated oncogenes, enhanced glycolytic …
In cultured cells transformed by vi ruses or activated oncogenes, enhanced glycolytic …
[HTML][HTML] Efficacy and safety of intravitreal gene therapy for Leber hereditary optic neuropathy treated within 6 months of disease onset
…, J Al-Tamami, A Pressler, C Schertler, M Hildebrandt… - Ophthalmology, 2021 - Elsevier
Purpose To evaluate the efficacy of a single intravitreal injection of rAAV2/2-ND4 in subjects
with visual loss from Leber hereditary optic neuropathy (LHON). Design RESCUE is a …
with visual loss from Leber hereditary optic neuropathy (LHON). Design RESCUE is a …
[HTML][HTML] Human cytomegalovirus (HCMV)–revised
…, L Gürtler, M Heiden, M Hildebrandt… - Transfusion medicine …, 2010 - ncbi.nlm.nih.gov
Together with animal cytomegalovirus, human cytomegalovirus (HCMV), also referred to in
recent literature as human herpes virus 5 (HHV-5), belongs to the Herpesviridae family, …
recent literature as human herpes virus 5 (HHV-5), belongs to the Herpesviridae family, …
Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma
T Stühmer, M Chatterjee, M Hildebrandt, P Herrmann… - Blood, 2005 - ashpublications.org
Mutation of p53 is a rare event in multiple myeloma, but it is unknown if p53 signaling is
functional in myeloma cells, and if targeted nongenotoxic activation of the p53 pathway is …
functional in myeloma cells, and if targeted nongenotoxic activation of the p53 pathway is …
A guardian angel: the involvement of dipeptidyl peptidase IV in psychoneuroendocrine function, nutrition and immune defence
Dipeptidyl peptidase IV (DPP IV, also known as CD26; EC 3.4.14.5) is a non-integrin receptor
glycoprotein with multiple functions, including cell adhesion, cellular trafficking through the …
glycoprotein with multiple functions, including cell adhesion, cellular trafficking through the …
[HTML][HTML] Orthopox viruses: infections in humans
…, L Gürtler, M Heiden, M Hildebrandt… - Transfusion Medicine …, 2010 - ncbi.nlm.nih.gov
Human smallpox caused by the variola virus (VARV) presented a threat for humans world-wide
for centuries. The successful eradication of smallpox was possible thanks to …
for centuries. The successful eradication of smallpox was possible thanks to …
Drug induced immune haemolytic anaemia in the Berlin Case‐Control Surveillance Study
…, H Schrezenmeier, M Hildebrandt… - British journal of …, 2011 - Wiley Online Library
Drug‐induced immune haemolytic anaemia is a rare but serious condition. This study
investigated the possibility of drug aetiology of immune haemolytic anaemia (IHA) in 134 patients …
investigated the possibility of drug aetiology of immune haemolytic anaemia (IHA) in 134 patients …
Coxiella burnetii–pathogenic agent of Q (query) fever
…, A Groener, M Heiden, M Hildebrandt… - Transfusion medicine …, 2014 - karger.com
C. burnetii is a member of the family of the Coxiellaceae bacteria and replicates intracellularly
in cells of different species. Phylogenetically related bacteria include Legionellaceae, …
in cells of different species. Phylogenetically related bacteria include Legionellaceae, …
Regulation of advanced therapy medicinal products in Europe and the role of academia
KF Pearce, M Hildebrandt, H Greinix, S Scheding… - Cytotherapy, 2014 - Elsevier
Background aims Advanced therapy medicinal products (ATMP) are gene therapy, somatic
cell therapy or tissue-engineered products regulated under (EC) No. 1394/2007 to ensure …
cell therapy or tissue-engineered products regulated under (EC) No. 1394/2007 to ensure …